Skip to main content Homepage

Medication-Assisted Treatment and Recovery (U MATR)

The Oregon Health Authority, operating under OAR 415.020, is in charge of helping and regulating addiction prevention and treatment services in Oregon. The Opioid Treatment Programs dispenses and administers medications for the treatment of opioid addiction. This includes delivery of counseling, supportive services and medical services to program participants.

Know Your Rights

Frequently Asked Questions

Answer: Research shows several positive benefits to methadone treatment, including reduced intravenous drug use, decreased risk of overdose and reduced exposure to infectious diseases (including Hepatitis C, B as well as HIV), up to 30% reduced mortality, reduced criminal behavior and improved pregnancy outcomes. Individuals on medication assisted treatment experience greatly reduced withdrawal symptoms, cravings, and are retained in a structured treatment environment for longer periods of time than those opioid dependent individuals undergoing other types of treatment.
Answer: Several other medication assisted treatment options are available for the treatment of opioid dependence, including buprenorphine and naltrexone. As opposed to methadone, which is a “full” agonist, buprenorphine is a partial agonist (partially binding to opioid receptors in the brain) and naltrexone is a full antagonist (fully blocking the opioid receptors in the brain). All of these medications are highly effective for the treatment of opioid dependence and may or may not be appropriate for the patient based on several other factors.
Answer: Currently, in the United States, methadone for the treatment of addiction can only be dispensed at an approved and regulated opiate treatment program; naltrexone and buprenorphine products can be prescribed by a physician for use by the patient in a non-office setting. As with any medication based intervention, engagement in treatment and a psychosocial support system can prove highly valuable in the patient being successful in this type of treatment.
Answer: Opioid addiction is one of Oregon’s most pressing public health issues. Lost productivity, overdose, and reduced quality of life are just some of the impacts to individuals, families, and society. Even when the individual has a strong desire to stop their usage, stopping opiate use after a long period can cause unpleasant physical and psychological withdrawal systems; many long time users find it difficult to not use opiates when faced with these symptoms, thus continuing the cycle of addiction. Medication Assisted Treatment (MAT), including the use of methadone, is a medically monitored therapeutic intervention designed to assist opiate dependent individuals improve their overall quality of life and begin the recovery process, that involves case management, counseling and medication management.
Program Contact:

Dr. John W. McIlveen
Program and Policy Development Specialist
State Opioid Treatment Authority

Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how